<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Stock Analysis: Johnson &amp; Johnson (JNJ) Still Buying At This Price *</title>
	<atom:link href="http://dividendsvalue.com/1454/stock-analysis-johnson-johnson-jnj-still-buying-at-this-price/feed/" rel="self" type="application/rss+xml" />
	<link>http://dividendsvalue.com/1454/stock-analysis-johnson-johnson-jnj-still-buying-at-this-price/</link>
	<description>Dividend Investing &#38; Value Investing For A Superior Portfolio</description>
	<lastBuildDate>Mon, 11 Apr 2011 13:45:49 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
	<item>
		<title>By: Anonymous</title>
		<link>http://dividendsvalue.com/1454/stock-analysis-johnson-johnson-jnj-still-buying-at-this-price/comment-page-1/#comment-2749</link>
		<dc:creator>Anonymous</dc:creator>
		<pubDate>Fri, 21 Nov 2008 18:46:00 +0000</pubDate>
		<guid isPermaLink="false">http://dividendsvalue.com/1454/stock-analysis-johnson-johnson-jnj-still-buying-at-this-price/#comment-2749</guid>
		<description>JNJ is not really a health care company. They get a large portion of their income from their finanacial arm. And that portion is growing. They are a multitude of business wrapped up so tightly that transparency is essentially lost. If your analysis restricts itself purley to dividends, thats fine...but I find this company very hard to understand from a complete financial postion and feel they can easily hide bad news. The fact that they are not in the paper often and not reporting bad news is not comforting to me. I stay far away from non-transparent companies like this.....  Just my two cents. So far, buying JNJ has seemingly been successful for others, so..Go for it!!</description>
		<content:encoded><![CDATA[<p>JNJ is not really a health care company. They get a large portion of their income from their finanacial arm. And that portion is growing. They are a multitude of business wrapped up so tightly that transparency is essentially lost. If your analysis restricts itself purley to dividends, thats fine&#8230;but I find this company very hard to understand from a complete financial postion and feel they can easily hide bad news. The fact that they are not in the paper often and not reporting bad news is not comforting to me. I stay far away from non-transparent companies like this&#8230;..  Just my two cents. So far, buying JNJ has seemingly been successful for others, so..Go for it!!</p>
]]></content:encoded>
	</item>
</channel>
</rss>

